Daily updates; gay keep: The latest news and trends in gay culture and entertainment

A handful of researchers, including the team I work with at Northwestern University, are chipping away at this problem by developing such programs. In the meantime, there is one potent tool that can curb the HIV epidemic in teens: a once-daily pill.

Daily updates; gay keep.

Download Zip: https://tinourl.com/2vCl8f

In May 2018, the Food and Drug Administration approved a once-daily pill called Truvada that combines two anti-HIV drugs, tenofovir and emtricitabine, for HIV prevention in teenagers weighing at least 77 pounds. This pill is part of a strategy known as pre-exposure prophylaxis (PrEP), which can prevent HIV from taking hold and spreading throughout the body. Truvada was approved for HIV prevention among adults in 2012 and has been used treat HIV since 2004.

Lesbian, gay, bisexual, and transgender people in America continue to face discrimination in their daily lives. While more states every year work to pass laws to protect LGBTQ people, we continue to see state legislatures advancing bills that target transgender people, limit local protections, and allow the use of religion to discriminate.

AIDS drugs line a pharmacy's shelves. A new recommendation from the World Health Organization suggests a daily anti-HIV pill for men who have sex with men. Astrid Riecken/MCT/Landov hide caption

The World Health Organization has thrown its weight behind a controversial strategy for curbing the spread of HIV/AIDS: Today the organization strongly recommended that men who have sex with men consider taking a daily pill that prevents infection with the virus.

The prevention pill, called pre-exposure prophylaxis, or PrEP, is a combination of two drugs used to treat people with HIV. By taking PrEP daily, an uninfected person can greatly reduce his chances of contracting the AIDS virus from an infected partner.

PrEP must be taken daily for at least seven days before it is effective at preventing HIV transmission through anal sex. This is because PrEP tends to collect in the colorectal tissue first before it is more present in other bodily tissues. However, it is still recommended that condoms are used during intercourse for additional protection.

Two years to the day after the U.S. Food and Drug Administration approved a once-daily pill to prevent HIV, the World Health Organization (WHO) has endorsed it as essential to prevent transmission of the virus in high-risk groups.

When PrEP was first introduced, taking it on a daily basis was the recommendation for everyone. Since then, research has found there to be new ways for taking PrEP that are just as effective as daily dosing.

Daily PrEP can suit people for a range of reasons. If you want to be protected from HIV without having to anticipate when your next sexual encounter may be, if you have a generally busy sex life or if you just prefer the structure of routine dosing, daily PrEP can work for you.

In the 1990s, the longstanding bonds between lesbian, gay, and bisexual people in both daily life and liberation activism led to the widespread adoption of the LGB acronym (lesbian, gay and bisexual).

With over 29 years of experience, Ken Howard, LCSW, CST provides help for gay men to achieve their optimum quality of life in both their personal lives and careers. While a podcast cannot substitute therapy, this show is still invaluable! It provides education and reflects the work done at GayTherapyLA with clients, daily. From dating, mental health to religion, Ken covers it all!

PEP should be used only in emergency situations. It is not meant for regular use by people who may be exposed to HIV frequently. PEP is not intended to replace regular use of other HIV prevention methods, such as consistent use of condoms during sex or pre-exposure prophylaxis (PrEP). PrEP is different than PEP, in that people at risk for HIV take a specific HIV medicine daily to prevent getting HIV.

Daily PrEP: Daily PrEP involves people of any gender identity (cis-gender man, cis-gender woman or transgender man or woman) taking 1 pill once a day, every day. With daily PrEP, a person can feel protected from HIV whenever they have sex or inject substances. It is for people who have possible exposure to HIV on a frequent basis, or an unpredictable basis. An important benefit of daily PrEP is that the person is always protected and can establish a daily habit of taking the medication. Daily PrEP with Descovy may be a good option for people who have difficulty tolerating Truvada, including people who have kidney disease or osteoporosis.

On-Demand PrEP: On-demand PrEP is only for cis-gender men who have sex with men (MSM). On-demand PrEP involves taking 2 pills, 2-24 hours before a possible sexual exposure to HIV and then continuing to take 1 pill each day until 2 days after their last possible sexual exposure. The only PrEP medication approved for on-demand use is Truvada. If a cis-gender MSM has a single possible exposure, they would take 2 pills, 2-24 hours before having sex and then would take 1 pill each day for 2 additional days. If a person had several possible exposures over the course of 2 or more days, the person would take 2 pills, 2-24 hours before the possible exposure, then 1 pill for each day they are having sex, and then 1 pill each day for 2 days after the last possible exposure. On-demand PrEP is for cis-gender MSM who have occasional risk for HIV that can be predicted at least 2 hours in advance. Cis-gender women, cis-gender men who have sex with women, people of trans experience, and people who share injection equipment should choose daily PrEP, not on-demand PrEP.

On-demand PrEP is only for cis-gender MSM. Other individuals are not eligible for on-demand PrEP because studies have not demonstrated that it is effective for other populations. Before switching from daily PrEP to on-demand PrEP, or vice versa, a cis-gender MSM should consult with their healthcare provider.

PrEP is not intended to be a life-long program. Rather, it is a program where the healthcare provider works with you to develop an individualized plan with as many renewals of the prescription as you and the healthcare provider agree to. For many people, life circumstances change over time and the risk for HIV may be reduced or eliminated. You should discuss the issue of how long you want to take the PrEP medication with your provider. If for any reason you want to stop taking the PrEP medication, consult with the healthcare provider who prescribed it, or another provider who is familiar with PrEP. Generally speaking, cis-gender men taking on-demand PrEP should continue taking the PrEP medication for at least 2 days after any possible exposure. Anyone taking daily PrEP should continue taking the medication for 28 days after the last possible exposure.

We do not have the ability to offer email updates at this time. The Weekly Forecast of Great Lakes Water Levels is updated each week on Thursday afternoon or Friday morning depending on data availability.

Strengthening your mutual emotional intimacy through daily check-ins as well as time devoted to meaningful conversation will help you stay together through the inevitable conflicts that crop up in all relationships.

At Social Security, we understand that the holiday season may give some of us a break from daily routines and the time to rest and relax. We want your clients to know that our online services are available to help them do business with us in an easy, convenient, and secure way. This season, encourage your clients to sign up for a personal my Social Security account.

Your clients can learn more about these updates on our Medicare webpage at www.ssa.gov/medicare and our Medicare publication at www.ssa.gov/pubs/EN-05-10043.pdf. Please share this important information with your clients.

On September 22, we hosted a virtual National Disability Forum (NDF) on the topic COVID-19 and SSA Programs: Serving Our Beneficiaries through Unprecedented Times. There were 844 calls into the conference line. Commissioner Andrew Saul provided opening remarks. Jeffrey Buckner, Associate Commissioner, Strategic and Digital Communications welcomed the participants and provided agency updates. Steve Rollins, Esq., Deputy Associate Commissioner, Office of Disability Policy provided the NDF overview. Sam Richardson, Deputy Associate Commissioner, Office of Public Service and Operations Support, facilitated the open discussion for the morning session. Dawn Wiggins, Associate Commissioner, Office of Income Security Programs, facilitated the open discussion for the afternoon session. Rebecca Vallas, Senior Fellow, Center for American Progress, was the moderator. The panels included:

We will continue to update our website with information on the status of our offices. Please visit our COVID-19 page at www.ssa.gov/coronavirus for more information. Your clients can learn about the critical services we provide online or by phone, as well as other important updates. They can also subscribe to get an email or text message notification when we update the page so they can stay informed.

We updated a rule that has been in the works for a number of years and updates an outdated policy that made the inability to communicate in English a factor in awarding disability benefits. Learn more about why we are making this much-needed change on our blog at -rule-modernizes-how-we-award-disability-benefits. 2ff7e9595c